Prevention of Contrast-Induced Acute Kidney Injury: an Update

被引:88
作者
Chalikias, George [1 ]
Drosos, Ioannis [2 ]
Tziakas, Dimitrios N. [1 ]
机构
[1] Democritus Univ Thrace, Univ Cardiol Dept, Sch Med, Dragana 68131, Alexandroupolis, Greece
[2] Univ Med Ctr Mainz, Ctr Cardiol, Cardiol 1, Mainz, Germany
关键词
Contrast induced nephropathy; Acute kidney injury; Contrast media; Coronary angiography; Percutaneous coronary intervention; Prevention; RANDOMIZED CONTROLLED-TRIALS; MEDIUM-INDUCED NEPHROPATHY; HIGH-RISK PATIENTS; CORONARY-ANGIOGRAPHY; N-ACETYLCYSTEINE; SODIUM-BICARBONATE; RENAL-INSUFFICIENCY; ASCORBIC-ACID; CARDIAC-CATHETERIZATION; PERIPHERAL ANGIOGRAPHY;
D O I
10.1007/s10557-016-6683-0
中图分类号
R5 [内科学];
学科分类号
100201 [内科学];
摘要
Contrast-induced acute kidney injury (CI-AKI) is a common complication of intravascular administration of contrast media used in coronary angiography, percutaneous coronary intervention and other diagnostic and interventional procedures. This review article aims at summarizing the published literature regarding the prevention of CI-AKI, by focusing on available high-quality meta-analyses addressing this matter. Apart from adequate hydration, a number of pharmacologic agents have been proposed as potential candidates to be included in the routine preparation, prior to the patient's arrival in the cardiac catheterization laboratory. Among them, statins and N-acetylcysteine appear to be the most extensively studied ones. Throughout this article we present the available data on CI-AKI prevention and provide a critical clinical appraisal, as well as a summary of currently available guidelines.
引用
收藏
页码:515 / 524
页数:10
相关论文
共 82 条
[1]
Protective effect of apocynin, a NADPH-oxidase inhibitor, against contrast-induced nephropathy in the diabetic rats: A comparison with n-acetylcysteine [J].
Ahmad, Akbar ;
Mondello, Stefania ;
Di Paola, Rosanna ;
Mazzon, Emanuela ;
Esposito, Emanuela ;
Catania, Maria Antonietta ;
Italiano, Domenico ;
Mondello, Patrizia ;
Aloisi, Carmela ;
Cuzzocrea, Salvatore .
EUROPEAN JOURNAL OF PHARMACOLOGY, 2012, 674 (2-3) :397-406
[2]
The first histopathological evidence of trimetazidine for the prevention of contrast-induced nephropathy [J].
Akgullu, Cagdas ;
Saruhan, Tevger ;
Eryilmaz, Ufuk ;
Boyacioglu, Murat ;
Onbasili, Osman Alper ;
Meteoglu, Ibrahim ;
Kum, Cavit .
RENAL FAILURE, 2014, 36 (04) :575-580
[3]
[Anonymous], 2016, NEW DEVICE REDUCES V
[4]
Ascorbic acid: much more than just an antioxidant [J].
Arrigoni, O ;
De Tullio, MC .
BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS, 2002, 1569 (1-3) :1-9
[5]
Intrarenal application of N-acetylcysteine for the prevention of contrast medium-induced nephropathy in primary angioplasty [J].
Aslanger, Emre ;
Uslu, Bora ;
Akdeniz, Cansu ;
Polat, Nihat ;
Cizgici, Yasar ;
Oflaz, Huseyin .
CORONARY ARTERY DISEASE, 2012, 23 (04) :265-270
[6]
Attallah N, 2004, CLIN NEPHROL, V62, P273
[7]
Acetylcysteine for prevention of contrast-induced nephropathy after intravascular angiography: A systematic review and meta-analysis [J].
Bagshaw, Sean M. ;
Ghali, William A. .
BMC MEDICINE, 2004, 2 (1)
[8]
Effects of withdrawing vs continuing renin-angiotensin blockers on incidence of acute kidney injury in patients with renal insufficiency undergoing cardiac catheterization: Results from the Angiotensin Converting Enzyme Inhibitor/Angiotensin Receptor Blocker and Contrast Induced Nephropathy in Patients Receiving Cardiac Catheterization (CAPTAIN) trial [J].
Bainey, Kevin R. ;
Rahim, Sherali ;
Etherington, Krystal ;
Rokoss, Michael L. ;
Natarajan, Madhu K. ;
Velianou, James L. ;
Brons, Sonya ;
Mehta, Shamir R. .
AMERICAN HEART JOURNAL, 2015, 170 (01) :110-116
[9]
Contrast-induced nephropathy [J].
Bartorelli, Antonio L. ;
Marenzi, Giancarlo .
JOURNAL OF INTERVENTIONAL CARDIOLOGY, 2008, 21 (01) :74-85
[10]
The impact of renal insufficiency on clinical outcomes in patients undergoing percutaneous coronary interventions [J].
Best, PJM ;
Lennon, R ;
Ting, HH ;
Bell, MR ;
Rihal, CS ;
Holmes, DR ;
Berger, PB .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2002, 39 (07) :1113-1119